34.060
34.06 (0%)
As of Dec 24, 2024
Harmony Biosciences Holdings, Inc. [HRMY]
Source:
Company Overview
Harmony Biosciences Holdings, Inc. is a commercial-stage, pharmaceutical company focused on developing and commercializing innovative therapies for patients living with rare neurological diseases as well as patients living with other neurological diseases who have unmet medical needs.
| Country | United States |
| Headquarters | plymouth meeting, pennsylvania |
| Phone Number | (484) 539-9800 |
| Industry | |
| CEO | Jeffrey M. Dayno |
| Website | www.clinicaltrials.gov |